AKT1 and hepatocellular carcinoma: Meanwhile, down-regulation of miR-1271-5p alleviates FOXK2 inhibition in hepatocellular carcinoma cells, facilitating tumor growth and metastasis through the PI3K/AKT signaling pathway (37).